164 related articles for article (PubMed ID: 12485616)
1. CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses.
Suzuki K; Kumanogoh A; Kikutani H
Cytokine Growth Factor Rev; 2003 Feb; 14(1):17-24. PubMed ID: 12485616
[TBL] [Abstract][Full Text] [Related]
2. The CD100-CD72 interaction: a novel mechanism of immune regulation.
Kumanogoh A; Kikutani H
Trends Immunol; 2001 Dec; 22(12):670-6. PubMed ID: 11738997
[TBL] [Abstract][Full Text] [Related]
3. Biological functions and signaling of a transmembrane semaphorin, CD100/Sema4D.
Kumanogoh A; Kikutani H
Cell Mol Life Sci; 2004 Feb; 61(3):292-300. PubMed ID: 14770294
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of the immune semaphorin CD100/SEMA4D.
Elhabazi A; Marie-Cardine A; Chabbert-de Ponnat I; Bensussan A; Boumsell L
Crit Rev Immunol; 2003; 23(1-2):65-81. PubMed ID: 12906260
[TBL] [Abstract][Full Text] [Related]
5. Roles of the semaphorin family in immune regulation.
Kumanogoh A; Kikutani H
Adv Immunol; 2003; 81():173-98. PubMed ID: 14711056
[TBL] [Abstract][Full Text] [Related]
6. Immune semaphorins: a new area of semaphorin research.
Kumanogoh A; Kikutani H
J Cell Sci; 2003 Sep; 116(Pt 17):3463-70. PubMed ID: 12893810
[TBL] [Abstract][Full Text] [Related]
7. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses.
Ishida I; Kumanogoh A; Suzuki K; Akahani S; Noda K; Kikutani H
Int Immunol; 2003 Aug; 15(8):1027-34. PubMed ID: 12882840
[TBL] [Abstract][Full Text] [Related]
8. The emerging roles of semaphorin4D/CD100 in immunological diseases.
Wang L; Li X; Song Y; Song D; Huang D
Biochem Soc Trans; 2020 Dec; 48(6):2875-2890. PubMed ID: 33258873
[TBL] [Abstract][Full Text] [Related]
9. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.
Kumanogoh A; Watanabe C; Lee I; Wang X; Shi W; Araki H; Hirata H; Iwahori K; Uchida J; Yasui T; Matsumoto M; Yoshida K; Yakura H; Pan C; Parnes JR; Kikutani H
Immunity; 2000 Nov; 13(5):621-31. PubMed ID: 11114375
[TBL] [Abstract][Full Text] [Related]
10. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice.
Shi W; Kumanogoh A; Watanabe C; Uchida J; Wang X; Yasui T; Yukawa K; Ikawa M; Okabe M; Parnes JR; Yoshida K; Kikutani H
Immunity; 2000 Nov; 13(5):633-42. PubMed ID: 11114376
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration.
Delaire S; Billard C; Tordjman R; Chédotal A; Elhabazi A; Bensussan A; Boumsell L
J Immunol; 2001 Apr; 166(7):4348-54. PubMed ID: 11254688
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immune responses in transgenic mice expressing a truncated form of the lymphocyte semaphorin CD100.
Watanabe C; Kumanogoh A; Shi W; Suzuki K; Yamada S; Okabe M; Yoshida K; Kikutani H
J Immunol; 2001 Oct; 167(8):4321-8. PubMed ID: 11591755
[TBL] [Abstract][Full Text] [Related]
13. Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses.
Wang X; Kumanogoh A; Watanabe C; Shi W; Yoshida K; Kikutani H
Blood; 2001 Jun; 97(11):3498-504. PubMed ID: 11369643
[TBL] [Abstract][Full Text] [Related]
14. Soluble SEMA4D/CD100: A novel immunoregulator in infectious and inflammatory diseases.
Maleki KT; Cornillet M; Björkström NK
Clin Immunol; 2016 Feb; 163():52-9. PubMed ID: 26732857
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis.
Elhabazi A; Delaire S; Bensussan A; Boumsell L; Bismuth G
J Immunol; 2001 Apr; 166(7):4341-7. PubMed ID: 11254687
[TBL] [Abstract][Full Text] [Related]
16. CD100 is a leukocyte semaphorin.
Delaire S; Elhabazi A; Bensussan A; Boumsell L
Cell Mol Life Sci; 1998 Nov; 54(11):1265-76. PubMed ID: 9849618
[TBL] [Abstract][Full Text] [Related]
17. [Relapsing-remitting multiple sclerosis: clinical and immunological aspects of the pathology on the example Sema4D and CD72].
Danchenko IY; Baidina TV; Kuklina EM; Trushnikova TN; Nekrasova IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10. Vyp. 2):63-71. PubMed ID: 31934990
[TBL] [Abstract][Full Text] [Related]
18. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2.
Kumanogoh A; Marukawa S; Suzuki K; Takegahara N; Watanabe C; Ch'ng E; Ishida I; Fujimura H; Sakoda S; Yoshida K; Kikutani H
Nature; 2002 Oct; 419(6907):629-33. PubMed ID: 12374982
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients.
Besliu A; Banica L; Predeteanu D; Vlad V; Ionescu R; Pistol G; Opris D; Berghea F; Stefanescu M; Matache C
Autoimmunity; 2011 Aug; 44(5):427-36. PubMed ID: 21244334
[TBL] [Abstract][Full Text] [Related]
20. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells.
Kumanogoh A; Suzuki K; Ch'ng E; Watanabe C; Marukawa S; Takegahara N; Ishida I; Sato T; Habu S; Yoshida K; Shi W; Kikutani H
J Immunol; 2002 Aug; 169(3):1175-81. PubMed ID: 12133937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
